iRhythm Technologies Management
Management criteria checks 1/4
iRhythm Technologies' CEO is Quentin Blackford, appointed in Oct 2021, has a tenure of 2.5 years. total yearly compensation is $16.60M, comprised of 4.1% salary and 95.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $8.09M. The average tenure of the management team and the board of directors is 1.9 years and 6.8 years respectively.
Key information
Quentin Blackford
Chief executive officer
US$16.6m
Total compensation
| CEO salary percentage | 4.1% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.2% |
| Management average tenure | 1.9yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't
Mar 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results
Feb 25iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?
Feb 02iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate
Dec 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Dec 20Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Dec 02Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Sep 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Aug 30When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jul 04Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Jun 16Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
May 26iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark
May 08What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?
Mar 27Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?
Feb 25Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Nov 24iRhythm falls after reaffirming 2022 guidance
Sep 21iRhythm: Fairly Priced At Current Multiples, No Need To Size Up
Sep 02Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Aug 18iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance
Aug 04iRhythm Technologies provides FY22 prelims, commercial chief resigns
Jul 19iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact
Jun 08Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Apr 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$17m | US$677k | -US$123m |
| Sep 30 2023 | n/a | n/a | -US$105m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$105m |
| Dec 31 2022 | US$8m | US$650k | -US$116m |
| Sep 30 2022 | n/a | n/a | -US$128m |
| Jun 30 2022 | n/a | n/a | -US$131m |
| Mar 31 2022 | n/a | n/a | -US$124m |
| Dec 31 2021 | US$10m | US$163k | -US$101m |
Compensation vs Market: Quentin's total compensation ($USD16.60M) is above average for companies of similar size in the US market ($USD6.59M).
Compensation vs Earnings: Quentin's compensation has increased whilst the company is unprofitable.
CEO
Quentin Blackford (44 yo)
2.5yrs
Tenure
US$16,595,149
Compensation
Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$16.60m | 0.23% $ 8.1m | |
| Chief Financial Officer | 1.7yrs | US$5.28m | 0.0085% $ 296.7k | |
| Chief Medical & Scientific Officer and Executive VP of Product Innovation | 2yrs | US$5.32m | 0.011% $ 388.7k | |
| Chief Business & Legal Officer | 2.3yrs | US$5.33m | 0.031% $ 1.1m | |
| Chief Commercial Officer | 1.8yrs | US$5.77m | 0.017% $ 596.6k | |
| Executive Vice President of Business Operations | less than a year | no data | no data | |
| Senior VP of Finance & Chief Accounting Officer | less than a year | no data | no data | |
| Chief Technology Officer | 2yrs | US$3.46m | 0.20% $ 6.8m | |
| Executive VP of Corporate Development & Investor Relations | 4.8yrs | US$3.54m | 0.098% $ 3.4m | |
| Executive Advisor | 1.1yrs | US$2.72m | 0.055% $ 1.9m | |
| Executive VP & Chief Risk Officer | 1.9yrs | no data | 0.079% $ 2.7m | |
| Director of Investor Relations | no data | no data | no data |
1.9yrs
Average Tenure
44yo
Average Age
Experienced Management: IRTC's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.3yrs | US$16.60m | 0.23% $ 8.1m | |
| Independent Director | 6.8yrs | US$233.12k | 0.028% $ 972.7k | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.8yrs | US$240.25k | 0.026% $ 899.9k | |
| Independent Chairman | 7.9yrs | US$286.74k | 0.029% $ 1.0m | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6yrs | US$230.62k | 0.014% $ 490.0k | |
| Independent Director | 8.1yrs | US$227.70k | 0.030% $ 1.0m | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.4yrs | US$239.97k | 0.011% $ 395.3k | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data |
6.8yrs
Average Tenure
66yo
Average Age
Experienced Board: IRTC's board of directors are considered experienced (6.8 years average tenure).